1. Home
  2. CNTA
  3. CNTA News

Latest Centessa Pharmaceuticals plc (CNTA) News on April 19, 2025

CNTA

MT Newswires

19 days ago

Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
CNTA

GlobeNewswire

a month ago

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting
CNTA

GlobeNewswire

a month ago

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

CNTA

MT Newswires

2 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $588,944, According to a Recent SEC Filing

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
CNTA

GlobeNewswire

3 months ago

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Why Is Centessa Pharmaceuticals (CNTA) Among the Best Medical Stocks to Buy Under $20?
CNTA

Insider Monkey

3 months ago

Why Is Centessa Pharmaceuticals (CNTA) Among the Best Medical Stocks to Buy Under $20?

Is Centessa Pharmaceuticals plc (CNTA) the Best Growth Stock to Buy Now Under $25?
CNTA

Insider Monkey

3 months ago

Is Centessa Pharmaceuticals plc (CNTA) the Best Growth Stock to Buy Now Under $25?

Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
CNTA

GlobeNewswire

3 months ago

Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer

CNTA

MT Newswires

3 months ago

TD Cowen Initiates Centessa Pharmaceuticals ADR at Buy

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Could Be 30% Below Their Intrinsic Value Estimate
CNTA

Simply Wall St.

4 months ago

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Could Be 30% Below Their Intrinsic Value Estimate

CNTA

MT Newswires

4 months ago

Centessa Pharmaceuticals Secures Loan Facility, Repays Debt

CNTA

MT Newswires

4 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $959,057, According to a Recent SEC Filing

Why Did Centessa Pharmaceuticals PLC (CNTA) Jump Yesterday?
CNTA

Insider Monkey

4 months ago

Why Did Centessa Pharmaceuticals PLC (CNTA) Jump Yesterday?

CNTA

MT Newswires

4 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $284,010, According to a Recent SEC Filing

CNTA

MT Newswires

4 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $1,615,255, According to a Recent SEC Filing

CNTA

MT Newswires

5 months ago

Morgan Stanley Lifts Price Target on Centessa Pharmaceuticals to $27 From $26, Keeps Overweight Rating

Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing
CNTA

BioPharma Dive

5 months ago

Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing

CNTA

MT Newswires

5 months ago

Centessa Pharmaceuticals' Q3 Loss Widens

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
CNTA

GlobeNewswire

5 months ago

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
CNTA

GlobeNewswire

5 months ago

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

CNTA

MT Newswires

6 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $863,727, According to a Recent SEC Filing

Centessa Pharmaceuticals Plc (CNTA): A Small-Cap Leader in Clinical-Stage Biotech
CNTA

Insider Monkey

6 months ago

Centessa Pharmaceuticals Plc (CNTA): A Small-Cap Leader in Clinical-Stage Biotech

Analysts Rate Centessa Pharmaceuticals Plc (CNTA) as Strong Buy Amid Promising Developments
CNTA

Insider Monkey

6 months ago

Analysts Rate Centessa Pharmaceuticals Plc (CNTA) as Strong Buy Amid Promising Developments

Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
CNTA

GlobeNewswire

7 months ago

Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

CNTA

MT Newswires

7 months ago

Centessa Pharmaceuticals Shares Rise After Upgrade From Morgan Stanley

CNTA

MT Newswires

7 months ago

Morgan Stanley Upgrades Centessa Pharmaceuticals to Overweight From Equalweight, Adjusts PT to $26 From $11

CNTA

MT Newswires

7 months ago

Update: B. Riley Initiates Centessa Pharmaceuticals at Buy With $33 Price Target

CNTA

MT Newswires

7 months ago

B. Riley Initiates Centessa Pharmaceuticals at Buy

CNTA

MT Newswires

7 months ago

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday

CNTA

MT Newswires

7 months ago

Sector Update: Health Care

CNTA

MT Newswires

7 months ago

Centessa Pharmaceuticals Prices Upsized $225 Million Public Offering

CNTA

MT Newswires

7 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $2,891,823, According to a Recent SEC Filing

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares
CNTA

GlobeNewswire

7 months ago

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

CNTA

MT Newswires

7 months ago

Centessa Pharmaceuticals Files Mixed Shelf; Launches $150 Million Offering of American Depositary Shares

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
CNTA

GlobeNewswire

7 months ago

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

Centessa Reverses Lower Despite $5 Billion Narcolepsy Opportunity
CNTA

Investor's Business Daily

7 months ago

Centessa Reverses Lower Despite $5 Billion Narcolepsy Opportunity

CNTA

MT Newswires

7 months ago

Top Midday Gainers

CNTA

MT Newswires

7 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

CNTA

MT Newswires

7 months ago

Sector Update: Health Care

CNTA

MT Newswires

7 months ago

Centessa Pharmaceuticals Shares Up After Drug Trial Found to Restore Wakefulness in Subjects

Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteers
CNTA

Benzinga

7 months ago

Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteers

Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity
CNTA

Investor's Business Daily

7 months ago

Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity

Investors are waking up to Centessa’s sleepiness drug
CNTA

BioPharma Dive

7 months ago

Investors are waking up to Centessa’s sleepiness drug

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
CNTA

GlobeNewswire

7 months ago

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

CNTA

MT Newswires

7 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $375,000, According to a Recent SEC Filing

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
CNTA

GlobeNewswire

8 months ago

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

Insider Sale: Chief Business Officer Gregory Weinhoff Sells 30,000 Shares of Centessa ...
CNTA

GuruFocus.com

8 months ago

Insider Sale: Chief Business Officer Gregory Weinhoff Sells 30,000 Shares of Centessa ...

CNTA

MT Newswires

8 months ago

Centessa Pharmaceuticals Insider Sold Shares Worth $573,905, According to a Recent SEC Filing

Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
CNTA

GlobeNewswire

8 months ago

Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Centessa Pharmaceuticals plc's (NASDAQ:CNTA) high institutional ownership speaks for itself as stock continues to impress, up 18% over last week
CNTA

Simply Wall St.

8 months ago

Centessa Pharmaceuticals plc's (NASDAQ:CNTA) high institutional ownership speaks for itself as stock continues to impress, up 18% over last week

CNTA

MT Newswires

8 months ago

Centessa Pharmaceuticals' Q2 Net Loss Widens

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024
CNTA

GlobeNewswire

8 months ago

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024

Are Medical Stocks Lagging Stryker (SYK) This Year?
CNTA

Zacks

9 months ago

Are Medical Stocks Lagging Stryker (SYK) This Year?

CNTA

MT Newswires

9 months ago

Oppenheimer Initiates Centessa Pharmaceuticals at Outperform Rating With $14 Price Target

Wall Street Analysts Believe Centessa Pharmaceuticals (CNTA) Could Rally 48.85%: Here's is How to Trade
CNTA

Zacks

9 months ago

Wall Street Analysts Believe Centessa Pharmaceuticals (CNTA) Could Rally 48.85%: Here's is How to Trade

CNTA

MT Newswires

10 months ago

Morgan Stanley Adjusts Price Target on Centessa Pharmaceuticals to $11 From $8, Maintains Equalweight Rating

CNTA

MT Newswires

10 months ago

Centessa Pharmaceuticals Appoints John Crowley as CFO

Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer
CNTA

GlobeNewswire

10 months ago

Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer

3 Major Product Releases at 3Shape Discover Event
CNTA

PR Newswire

10 months ago

3 Major Product Releases at 3Shape Discover Event

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
CNTA

GlobeNewswire

10 months ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029
CNTA

GlobeNewswire

10 months ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

EXCLUSIVE: Sunlight Creates Love Note Projections In New Fred Jewelry Collection
CNTA

WWD

10 months ago

EXCLUSIVE: Sunlight Creates Love Note Projections In New Fred Jewelry Collection

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series
CNTA

PR Newswire

10 months ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights
CNTA

GlobeNewswire

10 months ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results
CNTA

Insider Monkey

10 months ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options
CNTA

GlobeNewswire

10 months ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

Down -10.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Centessa Pharmaceuticals (CNTA)
CNTA

Zacks

a year ago

Down -10.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Centessa Pharmaceuticals (CNTA)

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

CNTA

MT Newswires

a year ago

Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares

CNTA

MT Newswires

a year ago

Centessa Pharmaceuticals Eyes $100 Million in ADS Offering

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024

CNTA

GuruFocus.com

a year ago

Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023

Centessa Pharmaceuticals PLC Chief People Officer Sells Company Shares
CNTA

GuruFocus.com

a year ago

Centessa Pharmaceuticals PLC Chief People Officer Sells Company Shares

Private equity firms who have a significant stake must be disappointed along with institutions after Centessa Pharmaceuticals plc's (NASDAQ:CNTA) market cap dropped by US$139m
CNTA

Simply Wall St.

a year ago

Private equity firms who have a significant stake must be disappointed along with institutions after Centessa Pharmaceuticals plc's (NASDAQ:CNTA) market cap dropped by US$139m

Centessa Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference

Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

Earnings Beat: Harmonic Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
CNTA

Simply Wall St.

a year ago

Earnings Beat: Harmonic Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Kevin Guest Calls on All to Connect during February Month of Friendship
CNTA

CNW Group

a year ago

Kevin Guest Calls on All to Connect during February Month of Friendship

CNTA

Thomson Reuters StreetEvents

a year ago

Q4 2023 Two Harbors Investment Corp Earnings Call

4 Accident & Health Insurers to Watch as Underwriting Exposure Increases
CNTA

Zacks

a year ago

4 Accident & Health Insurers to Watch as Underwriting Exposure Increases

Two Harbors Investment Corp (TWO) Reports Mixed Q4 Results Amid Market Volatility
CNTA

GuruFocus.com

a year ago

Two Harbors Investment Corp (TWO) Reports Mixed Q4 Results Amid Market Volatility

Two Harbors Investment Corp. Reports Fourth Quarter 2023 Financial Results
CNTA

Business Wire

a year ago

Two Harbors Investment Corp. Reports Fourth Quarter 2023 Financial Results

Here's Why Momentum in Soleno Therapeutics, Inc. (SLNO) Should Keep going
CNTA

Zacks

a year ago

Here's Why Momentum in Soleno Therapeutics, Inc. (SLNO) Should Keep going

Bread Financial Holdings (BFH) Tops Q4 Earnings and Revenue Estimates
CNTA

Zacks

a year ago

Bread Financial Holdings (BFH) Tops Q4 Earnings and Revenue Estimates

Two Harbors Investment Corp. Announces 2023 Dividend Tax Information
CNTA

Business Wire

a year ago

Two Harbors Investment Corp. Announces 2023 Dividend Tax Information

Fortune Brands Innovations (FBIN) Expected to Beat Earnings Estimates: Should You Buy?
CNTA

Zacks

a year ago

Fortune Brands Innovations (FBIN) Expected to Beat Earnings Estimates: Should You Buy?

4 Stocks With a Solid Net Profit Margin Worth Buying
CNTA

Zacks

a year ago

4 Stocks With a Solid Net Profit Margin Worth Buying

monday.com to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on Monday, February 12, 2024
CNTA

Business Wire

a year ago

monday.com to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on Monday, February 12, 2024

Q3 Earnings Highs And Lows: Inter Parfums (NASDAQ:IPAR) Vs The Rest Of The Personal Care Stocks
CNTA

StockStory

a year ago

Q3 Earnings Highs And Lows: Inter Parfums (NASDAQ:IPAR) Vs The Rest Of The Personal Care Stocks

Northwest Bancshares (NWBI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
CNTA

Zacks

a year ago

Northwest Bancshares (NWBI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
CNTA

GlobeNewswire

a year ago

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Is Now An Opportune Moment To Examine Dycom Industries, Inc. (NYSE:DY)?
CNTA

Simply Wall St.

a year ago

Is Now An Opportune Moment To Examine Dycom Industries, Inc. (NYSE:DY)?

Next Big Thing: 3  Biotech Stocks to Watch for Groundbreaking Advances
CNTA

InvestorPlace

a year ago

Next Big Thing: 3  Biotech Stocks to Watch for Groundbreaking Advances

Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
CNTA

Investor's Business Daily

a year ago

Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle

NETSTREIT Corp. Announces Dates for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
CNTA

Business Wire

a year ago

NETSTREIT Corp. Announces Dates for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Two Harbors Investment Corp. Announces Earnings Release and Conference Call for Fourth Quarter 2023 Financial Results
CNTA

Business Wire

a year ago

Two Harbors Investment Corp. Announces Earnings Release and Conference Call for Fourth Quarter 2023 Financial Results

Share on Social Networks: